The US Food and Drug Administration (FDA) announced that Strides Pharma, headquartered in India, is recalling approximately 89,592 bottles of Children’s Ibuprofen Oral Suspension 100 mg/5ml, a fever reducer and pain reliever. This batch was manufactured for distributor Taro Pharmaceuticals USA and distributed across the US market, according to Fox Business on 19/3.

The affected products are packaged in 4-ounce (approximately 118 ml) bottles, with lot numbers 7261973A and 7261974A, and an expiration date of 31/1/2027. Taro's products may be sold as generic drugs or under private label brands of retail chains.

The recall decision followed numerous consumer complaints regarding the presence of gel-like clumps and strange black particles within the liquid medication.

Illustration: Kernodle Clinic

The FDA classified this incident as Class II, a warning level for products that may cause temporary or medically reversible adverse health consequences. While the probability of serious complications is considered low, the FDA noted that foreign matter in liquid medication could pose a choking hazard for young children during use.

The cause of these impurities remains unclear, as does the exact number of contaminated bottles and their specific level of harm. To date, no reports of injuries or illnesses related to this batch of medication have been made.

Authorities advise consumers who have purchased recalled products to stop using them immediately. If a child has ingested this medication and exhibits unusual symptoms, parents should promptly take the child to a medical facility for examination and timely consultation.

This is not the only large-scale recall of pain relievers and fever reducers in recent times. Last December, Gold Star Distribution also recalled various fever and flu relief products, including DayQuil, Tylenol, Motrin, and Advil, after the FDA found evidence of feces, rat urine, and bird droppings at a storage facility in Minneapolis.

Binh Minh (According to Fox Business, Today)